These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12115398)

  • 41. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.
    Quenneville LA; Phillips KA; Ozcelik H; Parkes RK; Knight JA; Goodwin PJ; Andrulis IL; O'Malley FP
    Cancer; 2002 Nov; 95(10):2068-75. PubMed ID: 12412159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study.
    Maalej M; Hentati D; Messai T; Kochbati L; El May A; Mrad K; Romdhane KB; Ben Abdallah M; Zouari B
    Bull Cancer; 2008 Feb; 95(2):E5-9. PubMed ID: 18304901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endometrial cancer in the family-cancer database.
    Hemminki K; Vaittinen P; Dong C
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):1005-10. PubMed ID: 10566556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk.
    Hemminki K; Ji J; Försti A
    Cancer Res; 2007 Feb; 67(3):868-70. PubMed ID: 17283115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attributable risks of familial cancer from the Family-Cancer Database.
    Hemminki K; Czene K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1638-44. PubMed ID: 12496055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
    Fondrinier E; Guérin O; Lorimier G
    Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethnic differences in breast cancer risk and survival: a study on immigrants in Sweden.
    Mousavi SM; Försti A; Sundquist J; Hemminki K
    Acta Oncol; 2013 Nov; 52(8):1637-42. PubMed ID: 23317144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast.
    Buerger H; Mommers EC; Littmann R; Diallo R; Brinkschmidt C; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Böcker W
    Am J Clin Pathol; 2000 Dec; 114(6):854-9. PubMed ID: 11338473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk.
    Saetersdal A; Dørum A; Heimdal K; Helgerud P; Sager EM; Bøhler P; Tretli S; Kvinnsland S; Møller P
    Anticancer Res; 1996; 16(4A):1989-92. PubMed ID: 8712731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectral morphometric characterization of breast carcinoma cells.
    Barshack I; Kopolovic J; Malik Z; Rothmann C
    Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial invasive and borderline ovarian tumors by proband status, age and histology.
    Hemminki K; Granström C
    Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breastfeeding and prognostic markers in breast cancer.
    Lööf-Johanson M; Brudin L; Sundquist M; Thorstenson S; Rudebeck CE
    Breast; 2011 Apr; 20(2):170-5. PubMed ID: 20851603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of breast cancer in families of multiple affected women and men.
    Bevier M; Sundquist K; Hemminki K
    Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
    Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
    Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
    Simpson JF; O'Malley F; Dupont WD; Page DL
    Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Transplantation of human primary in-situ and invasive breast carcinoma in nude mice].
    He L; Andersen JA
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):321-3. PubMed ID: 9387265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epidemiology of breast cancers in the Somme department (1990-1993)].
    Peng J; Dubreuil A; Raverdy N; Ganry O; Lorriaux A
    Ann Chir; 1997; 51(9):974-80. PubMed ID: 10868038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.